These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 24058562)
1. Hydrogen sulfide preconditioning protects rat liver against ischemia/reperfusion injury by activating Akt-GSK-3β signaling and inhibiting mitochondrial permeability transition. Zhang Q; Fu H; Zhang H; Xu F; Zou Z; Liu M; Wang Q; Miao M; Shi X PLoS One; 2013; 8(9):e74422. PubMed ID: 24058562 [TBL] [Abstract][Full Text] [Related]
2. Flurbiprofen, a cyclooxygenase inhibitor, protects mice from hepatic ischemia/reperfusion injury by inhibiting GSK-3β signaling and mitochondrial permeability transition. Fu H; Chen H; Wang C; Xu H; Liu F; Guo M; Wang Q; Shi X Mol Med; 2012 Sep; 18(1):1128-35. PubMed ID: 22714712 [TBL] [Abstract][Full Text] [Related]
3. Salidroside protects rat liver against ischemia/reperfusion injury by regulating the GSK-3β/Nrf2-dependent antioxidant response and mitochondrial permeability transition. Cai L; Li Y; Zhang Q; Sun H; Yan X; Hua T; Zhu Q; Xu H; Fu H Eur J Pharmacol; 2017 Jul; 806():32-42. PubMed ID: 28411054 [TBL] [Abstract][Full Text] [Related]
4. Ischemic preconditioning increases GSK-3β/β-catenin levels and ameliorates liver ischemia/reperfusion injury in rats. Yan Y; Li G; Tian X; Ye Y; Gao Z; Yao J; Zhang F; Wang S Int J Mol Med; 2015 Jun; 35(6):1625-32. PubMed ID: 25813855 [TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by preventing GSK-3beta-dependent opening of mPTP. Yao LL; Huang XW; Wang YG; Cao YX; Zhang CC; Zhu YC Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1310-9. PubMed ID: 20154265 [TBL] [Abstract][Full Text] [Related]
6. Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3β. Liu T; Fang Y; Liu S; Yu X; Zhang H; Liang M; Ding X Free Radic Biol Med; 2015 Apr; 81():170-82. PubMed ID: 25451640 [TBL] [Abstract][Full Text] [Related]
7. Role of glycogen synthase kinase 3β in protective effect of propofol against hepatic ischemia-reperfusion injury. Zhao G; Ma H; Shen X; Xu GF; Zhu YL; Chen B; Tie R; Qu P; Lv Y; Zhang H; Yu J J Surg Res; 2013 Nov; 185(1):388-98. PubMed ID: 23743186 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice. Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822 [TBL] [Abstract][Full Text] [Related]
9. Age-associated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart. Zhu J; Rebecchi MJ; Tan M; Glass PS; Brink PR; Liu L J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):611-9. PubMed ID: 20427381 [TBL] [Abstract][Full Text] [Related]
11. Panax quinquefolium saponin attenuates cardiomyocyte apoptosis and opening of the mitochondrial permeability transition pore in a rat model of ischemia/reperfusion. Li D; Liu M; Tao TQ; Song DD; Liu XH; Shi DZ Cell Physiol Biochem; 2014; 34(4):1413-26. PubMed ID: 25301366 [TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore. Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218 [TBL] [Abstract][Full Text] [Related]
13. Mediation of dopamine D2 receptors activation in post-conditioning-attenuated cardiomyocyte apoptosis. Li H; Wei C; Gao J; Bai S; Li H; Zhao Y; Li H; Han L; Tian Y; Yang G; Wang R; Wu L; Xu C Exp Cell Res; 2014 Apr; 323(1):118-130. PubMed ID: 24412422 [TBL] [Abstract][Full Text] [Related]
14. Liraglutide attenuates partial warm ischemia-reperfusion injury in rat livers. Abdelsameea AA; Abbas NA; Abdel Raouf SM Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):311-319. PubMed ID: 27986979 [TBL] [Abstract][Full Text] [Related]
15. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening. Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287 [TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide ameliorates ischemia/reperfusion-induced hepatitis by inhibiting apoptosis and autophagy pathways. Cheng P; Wang F; Chen K; Shen M; Dai W; Xu L; Zhang Y; Wang C; Li J; Yang J; Zhu R; Zhang H; Zheng Y; Lu J; Zhou Y; Guo C Mediators Inflamm; 2014; 2014():935251. PubMed ID: 24966472 [TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway. Wang Y; Li X; Wang X; Lau W; Wang Y; Xing Y; Zhang X; Ma X; Gao F PLoS One; 2013; 8(8):e70956. PubMed ID: 23976968 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of ischemic preconditioning and application of lipoic acid prior to 90 min of hepatic ischemia in a rat model. Duenschede F; Erbes K; Riegler N; Ewald P; Kircher A; Westermann S; Schad A; Miesmer I; Albrecht-Schöck S; Gockel I; Kiemer AK; Junginger T World J Gastroenterol; 2007 Jul; 13(27):3692-8. PubMed ID: 17659728 [TBL] [Abstract][Full Text] [Related]
19. The strategy of combined ischemia preconditioning and salvianolic acid-B pretreatment to prevent hepatic ischemia-reperfusion injury in rats. Kong R; Gao Y; Sun B; Chen H; Wang G; Wang X; Zhu H; Pan S; Xue D; Jiang H Dig Dis Sci; 2009 Dec; 54(12):2568-76. PubMed ID: 19156521 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21-Regulated Activation of the Akt Pathway Participates in the Protective Effects of H Lu M; Jiang X; Tong L; Zhang F; Ma L; Dong X; Sun X Biol Pharm Bull; 2018 Feb; 41(2):229-238. PubMed ID: 29187695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]